Metvix (PhotoCure)
Overview
Pharmacology
Authors
Affiliations
Metvix is a photosensitive cream containing the methyl ester of 5-aminolevulinic acid, which has been developed and launched by PhotoCure in Sweden for the treatment of high-risk basal cell carcinoma and actinic keratosis.
Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology.
Lou L, Zhou S, Tan S, Xiang M, Wang W, Yuan C Front Pharmacol. 2023; 14:1137707.
PMID: 36923350 PMC: 10008889. DOI: 10.3389/fphar.2023.1137707.
Omran Z, Dalhat M, Abdullah O, Kaleem M, Hosawi S, Al-Abbasi F Cancers (Basel). 2021; 13(8).
PMID: 33921128 PMC: 8071514. DOI: 10.3390/cancers13081916.
Passos S, de Souza P, Soares P, Eid D, Primo F, Tedesco A Clin Cosmet Investig Dermatol. 2013; 6:51-9.
PMID: 23450821 PMC: 3581285. DOI: 10.2147/CCID.S36758.
Perrett C, McGregor J, Warwick J, Karran P, Leigh I, Proby C Br J Dermatol. 2007; 156(2):320-8.
PMID: 17223873 PMC: 2423222. DOI: 10.1111/j.1365-2133.2006.07616.x.
Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells.
Rodriguez L, Batlle A, Di Venosa G, Battah S, Dobbin P, MacRobert A Br J Pharmacol. 2006; 147(7):825-33.
PMID: 16432502 PMC: 1751507. DOI: 10.1038/sj.bjp.0706668.